Synergistic Systems for Treating Inflammatory Bowel Disease through Peripheral Nerve Stimulation and AI-Powered Personalized Medicine
Legal Citation
Summary of the Inventive Concept
This inventive concept integrates peripheral nerve stimulation with AI, IoT, and blockchain technologies to create a personalized treatment system for inflammatory bowel disease, offering improved treatment outcomes and enhanced patient care.
Background and Problem Solved
The original patent disclosed a method for treating inflammatory bowel disease through peripheral nerve stimulation. However, it lacked the capability to provide personalized treatment recommendations, secure patient data management, and real-time monitoring of treatment response. The new inventive concept addresses these limitations by combining peripheral nerve stimulation with AI-powered diagnostic capabilities, IoT-enabled sensors, and blockchain-based patient data management.
Detailed Description of the Inventive Concept
The synergistic system consists of a peripheral nerve stimulation module, an AI-powered diagnostic module, and a blockchain-based patient data management system. The AI-powered diagnostic module analyzes the patient's medical history and provides personalized treatment recommendations. The peripheral nerve stimulation module delivers targeted electrical stimulation to the patient's peripheral nerves based on the AI-recommended treatment plan. The blockchain-based patient data management system securely stores and updates the patient's treatment records, ensuring data integrity and confidentiality. The system also incorporates IoT-enabled sensors to monitor the patient's vital signs and treatment response, transmitting the data to a cloud-based server for analysis and feedback.
Novelty and Inventive Step
The new inventive concept is novel and non-obvious in its combination of peripheral nerve stimulation with AI-powered diagnostics, IoT-enabled sensors, and blockchain-based patient data management. The integration of these distinct technologies enables personalized treatment recommendations, real-time monitoring, and secure data management, which are not possible with the original patent's method.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT sensor configurations, or alternative blockchain-based data management systems. Additionally, the system could be adapted for treating other inflammatory diseases or expanded to include additional diagnostic modalities.
Potential Commercial Applications and Market
The synergistic system has significant commercial potential in the healthcare industry, particularly in the treatment of inflammatory bowel disease. The system's ability to provide personalized treatment recommendations, real-time monitoring, and secure data management addresses a significant unmet need in the market. The target industries include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically neuromodulation and medical treatment systems for inflammatory gastrointestinal diseases, with expertise in electrical nerve stimulation, medical device design, and digital health technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees, knowledge of peripheral nerve stimulation techniques, familiarity with digital health technologies, and understanding of treatment protocols for inflammatory bowel diseases
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with existing peripheral nerve stimulation methods represents a predictable extension of the source patent's core technique. The addition of AI, IoT, and blockchain technologies to the fundamental nerve stimulation approach provides a logical progression of treatment monitoring and personalization. These technological augmentations would be considered routine optimization and enhancement of the original nerve stimulation method for inflammatory bowel disease treatment.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,778 |
|---|---|
| Title | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| Assignee(s) | Cala Health, Inc. |